Your browser doesn't support javascript.
loading
Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy.
Wudhikarn, Kitsada; Tomas, Ana Alarcon; Flynn, Jessica R; Devlin, Sean M; Brower, Jamie; Bachanova, Veronika; Nastoupil, Loretta J; McGuirk, Joseph P; Maziarz, Richard T; Oluwole, Olalekan O; Schuster, Stephen J; Porter, David L; Bishop, Michael R; Riedell, Peter A; Perales, Miguel-Angel.
Afiliação
  • Wudhikarn K; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Tomas AA; Division of Hematology and Research Unit in Translational Hematology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Flynn JR; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Devlin SM; Division of Hematology and Hemotherapy, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Brower J; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Bachanova V; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Nastoupil LJ; Blood and Marrow Transplant and Cellular Therapy Program, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.
  • McGuirk JP; Division of Hematology, Oncology, Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN.
  • Maziarz RT; Division of Cancer Medicine, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Oluwole OO; Division of Hematologic Malignancies and Cellular Therapeutics, Department of Medicine, The University of Kansas, Kansas City, KS.
  • Schuster SJ; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health & Science University, Portland, OR.
  • Porter DL; Division of Hematology/Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN.
  • Bishop MR; Blood and Marrow Transplant and Cellular Therapy Program, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.
  • Riedell PA; Blood and Marrow Transplant and Cellular Therapy Program, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.
  • Perales MA; The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL.
Blood Adv ; 7(13): 3192-3198, 2023 07 11.
Article em En | MEDLINE | ID: mdl-36355838
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Linfoma Difuso de Grandes Células B Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Linfoma Difuso de Grandes Células B Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article